Narrow search
Showing 1 - 10 of 1,037
Cover Image
From alternative development to sustainable development : the role of development within the global drug control regime
Brombacher, Daniel; Westerbarkei, Jan - In: Journal of illicit economies and development : JIED 1 (2019) 1, pp. 89-98
The concept of alternative development (AD) in international drug control has evolved over the past four decades, with … several major milestones between the two United Nations General Assembly Special Sessions on the World Drug Problem (UNGASS …) 1998 and 2016. However, it was not until UNGASS 2016 that the door for development-oriented thinking in international drug …
Persistent link: https://www.econbiz.de/10012260788
Cover Image
Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany
Pöllinger, Bernadette; Schmidt, Wolfgang; Seiffert, Anna; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 195-203
Persistent link: https://www.econbiz.de/10012004819
Cover Image
On the drivers of drug shortages : empirical evidence from Germany
Francas, David; Mohr, Stephan; Hoberg, Kai - In: International journal of operations & production management 43 (2023) 10, pp. 1520-1538
Persistent link: https://www.econbiz.de/10014381243
Cover Image
Mit dem Markt gegen Drogen!? : Lösungsansätze für das Drogenproblem aus ökonomischer Sicht
Erlei, Mathias (ed.) - 1995
Persistent link: https://www.econbiz.de/10000546344
Cover Image
Kontrollierte Heroinabgabe : Optionen einer künftigen Drogenpolitik ; eine ökonomische Betrachtung
Gersemann, Olaf - 1996
Persistent link: https://www.econbiz.de/10000928016
Cover Image
Effects of the German reference drug program on ex-factory prices of prescription drugs : a panel data approach
Augurzky, Boris; Göhlmann, Silja; Greß, Stefan; … - In: Health economics 18 (2009) 4, pp. 421-436
Persistent link: https://www.econbiz.de/10003844289
Cover Image
Cost of Multi Drug Resistance Tuberculosis in Germany
Diel, Roland; Nienhaus, Albert; Lampenius, Niklas; … - 2014
economic consequences of drug resistance patterns on the treatment costs of MDR-and XDR-TB patients. Methods: On the basis of … drug susceptibility of the single MDR-TB/XDR-TB strains the direct medical costs of suitable therapies were calculated … invoicing system and health statistics. Total drug and monitoring costs and were determined by Monte-Carlo simulation comprising …
Persistent link: https://www.econbiz.de/10014140995
Cover Image
Health care expenditures, innovation, and demographic change
Ilgin, Yasemin - 2008
Persistent link: https://www.econbiz.de/10003729378